Insider · CIK 0001520533

SCHLOSSBERG MARK A

Reports to the SEC for 3 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001520533

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-15	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	−25.2K sh	—	—	25,197
2022-03-15	CYTKCYTOKINETICS INCM Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	+4,803 sh	$14.40	+$69.2K	103,408
2022-03-15	CYTKCYTOKINETICS INCM Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	+30.8K sh	$7.03	+$217K	98,605
2022-03-15	CYTKCYTOKINETICS INCM Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	+25.2K sh	$14.40	+$363K	128,604
2022-03-15	CYTKCYTOKINETICS INCS Sale	SVP - Legal & General Counsel	SSale	−25.2K sh	$33.96	−$856K	103,408
2022-03-15	CYTKCYTOKINETICS INC · Incentive Stock Option (right to buy)M Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	−30.8K sh	—	—	13,938
2022-03-15	CYTKCYTOKINETICS INC · Incentive Stock Option (right to buy)M Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	−4,803 sh	—	—	4,804
2022-03-07	CYTKCYTOKINETICS INCF Tax Payment	SVP - Legal & General Counsel	FTax Payment	−4,631 sh	$36.83	−$171K	67,787
2022-03-02	CYTKCYTOKINETICS INCA Award	SVP - Legal & General Counsel	AAward	+20K sh	—	—	72,418
2022-03-02	CYTKCYTOKINETICS INC · Incentive Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+3,862 sh	$37.63	+$145K	3,862
2022-03-02	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+41.1K sh	$37.63	+$1.55M	41,138
2022-03-02	CYTKCYTOKINETICS INCF Tax Payment	SVP - Legal & General Counsel	FTax Payment	−3,457 sh	$37.63	−$130K	52,418
2022-02-16	CYTKCYTOKINETICS INCA Award	SVP - Legal & General Counsel	AAward	+1,900 sh	—	—	52,750
2022-02-16	CYTKCYTOKINETICS INCA Award	SVP - Legal & General Counsel	AAward	+3,125 sh	—	—	55,875
2021-10-19	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	−20K sh	—	—	15,265
2021-10-19	CYTKCYTOKINETICS INCM Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	+20K sh	$7.03	+$140K	70,829
2021-10-19	CYTKCYTOKINETICS INCS Sale	SVP - Legal & General Counsel	SSale	−20K sh	$35.74	−$714K	50,850
2021-03-08	CYTKCYTOKINETICS INCF Tax Payment	SVP - Legal & General Counsel	FTax Payment	−4,150 sh	$19.19	−$79.6K	50,850
2021-03-02	CYTKCYTOKINETICS INCA Award	SVP - Legal & General Counsel	AAward	+25K sh	—	—	55,000
2021-03-02	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+34.9K sh	$19.42	+$677K	34,871
2021-03-02	CYTKCYTOKINETICS INC · Incentive Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+10.1K sh	$19.42	+$197K	10,129
2020-08-21	CYTKCYTOKINETICS INCM Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	+10K sh	$7.03	+$70.3K	40,000
2020-08-21	CYTKCYTOKINETICS INCS Sale	SVP - Legal & General Counsel	SSale	−10K sh	$25.00	−$250K	30,000
2020-08-21	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	−10K sh	—	—	35,244
2020-07-29	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	−10K sh	—	—	45,244
2020-07-29	CYTKCYTOKINETICS INCM Exercise/Conversion	SVP - Legal & General Counsel	MExercise/Conversion	+10K sh	$7.03	+$70.3K	40,000
2020-07-29	CYTKCYTOKINETICS INCS Sale	SVP - Legal & General Counsel	SSale	−10K sh	$23.07	−$231K	30,000
2020-03-06	CYTKCYTOKINETICS INCA Award	SVP - Legal & General Counsel	AAward	+30K sh	—	—	30,000
2020-03-06	CYTKCYTOKINETICS INC · Incentive Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+9,607 sh	$14.40	+$138K	9,607
2020-03-06	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+50.4K sh	$14.40	+$726K	50,393
2019-01-31	CYTKCYTOKINETICS INC · Incentive Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+44.8K sh	$7.03	+$315K	44,756
2019-01-31	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (right to buy)A Award	SVP - Legal & General Counsel	AAward	+55.2K sh	$7.03	+$388K	55,244
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−21.7K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−100K sh	—	—	0
2018-05-04	Impax Laboratories, LLCD Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−50.1K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−52K sh	—	—	0
2018-05-04	Impax Laboratories, LLCD Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−18.1K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−55K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−47.5K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−52.8K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	SVP and General Counsel	DDisposition to Issuer	−56.2K sh	—	—	0
2018-03-02	Impax Laboratories, LLCF Tax Payment	SVP and General Counsel	FTax Payment	−3,273 sh	$19.50	−$63.8K	89,246
2018-02-26	Impax Laboratories, LLCF Tax Payment	SVP and General Counsel	FTax Payment	−5,937 sh	$20.95	−$124K	92,519
2017-05-15	Impax Laboratories, LLCF Tax Payment	SVP and General Counsel	FTax Payment	−3,488 sh	$16.80	−$58.6K	98,456
2017-05-14	Impax Laboratories, LLCF Tax Payment	SVP and General Counsel	FTax Payment	−3,235 sh	$17.65	−$57.1K	101,944
2017-03-02	Impax Laboratories, LLCStock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+56.2K sh	—	—	56,232
2017-03-02	Impax Laboratories, LLCA Award	SVP and General Counsel	AAward	+23.3K sh	—	—	105,179
2017-02-26	Impax Laboratories, LLCF Tax Payment	SVP and General Counsel	FTax Payment	−6,014 sh	$14.05	−$84.5K	81,907
2016-06-17	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+157K sh	—	—	156,750
2016-05-23	Impax Laboratories, LLCF Tax Payment	SVP and General Counsel	FTax Payment	−1,095 sh	$32.12	−$35.2K	87,921

Recent filings

Accepted (ET)
Mar 154
SCHLOSSBERG MARK A0001061983-22-000077
SEC(opens sec.gov)
Mar 84
SCHLOSSBERG MARK A0001061983-22-000070
SEC(opens sec.gov)
Mar 34
SCHLOSSBERG MARK A0001061983-22-000056
SEC(opens sec.gov)
Feb 174
SCHLOSSBERG MARK A0001061983-22-000028
SEC(opens sec.gov)
Oct 204
SCHLOSSBERG MARK A0001061983-21-000241
SEC(opens sec.gov)
Mar 94
SCHLOSSBERG MARK A0001061983-21-000078
SEC(opens sec.gov)
Mar 44
SCHLOSSBERG MARK A0001061983-21-000061
SEC(opens sec.gov)

Companies

Address

C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVE.

HAYWARD, CA, 94544